TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC

Immunochemotherapy and chemotherapy increase TLSs and granzyme B+ CD8+ T cells in tumors. The TLS area-to-tumor ratio distinguishes responders from non-responders, with PD-L1+ dendritic cells near CD8+PD-1+ T cells linked to efficacy, suggesting that PD-1 inhibitors disrupt harmful interactions. Post-immunochemotherapy, CD8+ T cells increase, but CD38+CD8+ T cells show reduced functionality. These findings highlight the complex immune dynamics and their implications for NSCLC treatment.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2024-12-11
DOI
https://doi.org/10.3389/fimmu.2024.1499731
Citations
6
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC

Jinqi You, Yan Tang, Ze-Rui Zhao, Jianchuan Xia et al.
6 citations
Frontiers in Immunology
Cancer Immunotherapy and Biomarkers
1.70
article

TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC

Jinqi You, Yan Tang, Ze-Rui Zhao, Jianchuan Xia, Haoran Zhong, Tong Xiang, Hao Long, Si Chen, Hao Chen, Chaopin Yang, Yizhi Wang, Runfei Song
article en
6 citations

Abstract

Immunochemotherapy and chemotherapy increase TLSs and granzyme B+ CD8+ T cells in tumors. The TLS area-to-tumor ratio distinguishes responders from non-responders, with PD-L1+ dendritic cells near CD8+PD-1+ T cells linked to efficacy, suggesting that PD-1 inhibitors disrupt harmful interactions. Post-immunochemotherapy, CD8+ T cells increase, but CD38+CD8+ T cells show reduced functionality. These findings highlight the complex immune dynamics and their implications for NSCLC treatment.

Frontiers in ImmunologyVol. 15
Sun Yat-sen University (CN), Sun Yat-sen University Cancer Center (CN)
Sun Yat-sen University, China Postdoctoral Science Foundation, Sun Yat-sen University Cancer Center
Good health and well-being
Openalex Percentile: Top 13%
Cancer Immunotherapy and Biomarkers
1.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC — Jinqi You, Yan Tang, et al. · Frontiers in Immunology (2024) | TGRS Research Map | TGRS